Taurus Diagnostics Inc (AKA: Taurus Dx) Profile last edited on: 2/15/2023
CAGE: 94XC5
UEI: LWZPC598N4J6
Business Identifier: Utilizing AI solutions to increase the accuracy of MRI while preventing unnecessary biopsies 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 22
County: Onondaga
Congr. District: 22
County: Onondaga
Public Profile
Taurus Diagnostics is a physician founded and lead startup that seeks to develop a novel diagnostic platform, and AI-based system capable of analyzing multiparametric MRI scans to rapidly and autonomously detect lesions concerning for clinically significant prostate cancer. By enabling a high-precision prostate cancer diagnostic solution that can be easily adopted by non-expert centers, the NGH system would significantly improve cancer diagnosis and detection of clinically significant prostate cancers (those with higher chance for metastases) and subsequently, management.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2022 | 1 | NSF | $256,000 | |
| Project Title: AI-based system for analyzing multiparametric MRI scans for prostate lesion detection | ||||
Key People / Management
Gennady Bratslavsky -- Co-Founder
Thomas Sanford -- Co-Founder
Thomas Sanford -- Co-Founder
Company News
There are no news available.
